Karriereverlauf von Kaye Spratt
Ehemalige bekannte Positionen von Kaye Spratt
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.1997 | 01.01.2015 |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Corporate Officer/Principal | - | - |
| ABEONA THERAPEUTICS INC. | General Counsel | 01.11.2015 | - |
Ausbildung von Kaye Spratt
| Meharry Medical College | Doctorate Degree |
| Langston University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
- Börse
- Insiders
- Kaye Spratt
- Erfahrung
